Journal
CIRCULATION
Volume 109, Issue 8, Pages 1022-1028Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.CIR.0000117403.64398.53
Keywords
apoptosis; atherosclerosis; lipoproteins; superoxide
Ask authors/readers for more resources
Background - Remnant lipoprotein particles ( RLPs), products of lipolytic degradation of triglyceride- rich lipoprotein derived from VLDL, exert atherogenesis. In this study, we observed how RLPs induced cytotoxicity in human umbilical vein endothelial cells ( HUVECs) and cilostazol prevented cell death. Methods and Results - RLPs were isolated from the plasma of hyperlipidemic patients by use of an immunoaffinity gel mixture of anti - apolipoprotein A- 1 and anti - apolipoprotein B- 100 monoclonal antibodies. RLPs ( 50 mu g/ mL) significantly increased superoxide formation in HUVECs associated with elevated gp91phox mRNA and protein expression and Rac1 translocation, accompanied by increased production of tumor necrosis factor ( TNF)-alpha and interleukin-1beta, DNA fragmentation, and cell death. Cilostazol ( 1 to 100 mumol/ L) significantly suppressed not only NAD( P)H oxidase - dependent superoxide production but also TNF-alpha and interleukin-1beta release and restored viability. RLPs activated a lectin- like oxidized low- density lipoprotein receptor- 1 ( LOX- 1), which was not inhibited by cilostazol. Treatment of HUVECs with monoclonal antibody for LOX- 1 attenuated RLP- mediated production of superoxide, TNF-alpha, and interleukin-1beta and DNA fragmentation. Conclusions - RLPs stimulated NAD( P) H oxidase - dependent superoxide formation and induction of cytokines in HUVECs via activation of LOX- 1, consequently leading to reduction in cell viability with DNA fragmentation, and cilostazol exerts a cell- protective effect by suppressing these variables.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available